BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21426070)

  • 21. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 24. Network measures for chemical library design.
    Sukumar N; Krein MP; Prabhu G; Bhattacharya S; Sen S
    Drug Dev Res; 2014 Sep; 75(6):402-11. PubMed ID: 25195584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular fields in drug discovery: getting old or reaching maturity?
    Cross S; Cruciani G
    Drug Discov Today; 2010 Jan; 15(1-2):23-32. PubMed ID: 19150413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo drug design: integration of structure-based and ligand-based methods.
    Dean PM; Lloyd DG; Todorov NP
    Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Computational chemistry in structure-based drug design].
    Cao R; Li W; Sun HZ; Zhou Y; Huang N
    Yao Xue Xue Bao; 2013 Jul; 48(7):1041-52. PubMed ID: 24133970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What has polar surface area ever done for drug discovery?
    Clark DE
    Future Med Chem; 2011 Mar; 3(4):469-84. PubMed ID: 21452982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D; Fogel GB
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docking methods for structure-based library design.
    Cavasotto CN; Phatak SS
    Methods Mol Biol; 2011; 685():155-74. PubMed ID: 20981523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing performance of computational tools for combinatorial library design.
    Evensen E; Eksterowicz JE; Stanton RV; Oshiro C; Grootenhuis PD; Bradley EK
    J Med Chem; 2003 Nov; 46(24):5125-8. PubMed ID: 14613315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.